Template:Antibacterial Spectra Key: Difference between revisions
No edit summary |
Ostermayer (talk | contribs) (Prepared the page for translation) |
||
| Line 1: | Line 1: | ||
<languages/> | |||
<translate> | |||
*'''S''' susceptible/sensitive (usually) | *'''S''' susceptible/sensitive (usually) | ||
*'''I''' intermediate (variably susceptible/resistant) | *'''I''' intermediate (variably susceptible/resistant) | ||
| Line 8: | Line 10: | ||
*'''X3''' active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis | *'''X3''' active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis | ||
*'''X4''' active in vitro, but not clinically effective for strep pneumonia | *'''X4''' active in vitro, but not clinically effective for strep pneumonia | ||
</translate> | |||
Revision as of 07:56, 23 January 2026
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia